Search For "drug controller general of india"
Subject Expert Panel recommends Corbevax COVID-19 vaccines for children ag
Updated : 4 years, 1 month ago IST
New Delhi [India], April 21 (ANI): The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) has recommended restricted emergency use of Biological E's Corbevax COVID-19 vaccine for children aged 5-11, said sources on Thursday.
Read More
Expert panel of DCGI holds meet to discuss recommendations to use COVID-19
Updated : 4 years, 1 month ago IST
New Delhi [India], April 21 (ANI): The meeting of the Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) is underway to discuss recommendations on restricted emergency use of Bharat Biotech's Covaxin and Biological E's Corbevax COVID-19 vaccine for children aged
Read More
DCGI claims India on course to become global drugs hub
Updated : 4 years, 1 month ago IST
New Delhi [India], April 14 (ANI): Claiming that India is on course to become a 'global hub for medicines', Dr VG Somani, Drug Controller General of India (DCGI), said that there has been a fourfold increase in applications of the investigational new drugs in the country.
Read More
Glenmark Specialty S.A. receives approval for conducting Phase 1 Clinical
Updated : 4 years, 1 month ago IST
Mumbai (Maharashtra) [India] April 11 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, an innovation-driven, global pharmaceutical company, announced that its subsidiary Glenmark Specialty S.A. (Glenmark) received approval from the Indian drug regulator, Drug Controller General of India (
Read More
Zydus Lifesciences gets DCGI approval for Oxemia drug
Updated : 4 years, 2 months ago IST
Ahmedabad (Gujarat) [India], March 7 (ANI): Zydus Lifesciences on Monday said it has received approval from the Drug Controller General of India (DCGI) for a new drug application, Oxemia (Desidustat), a first-of-its-kind oral treatment in India for anemia associated with chronic kidney disea
Read More
DCGI approves Themis Medicare's VIRALEX for Covid-19 treatment
Updated : 4 years, 2 months ago IST
New Delhi [India], March 5 (ANI/Target Media): In a landmark development for the treatment of COVID-19, Themis Medicare Ltd. (Themis), a Pharmaceutical company headquartered in Mumbai with a legacy of over 50 years of making new treatment options available, announced the approval of its a
Read More
Bharat Biotech gets SEC approval for phase 3 clinical trials of COVID boos
Updated : 4 years, 4 months ago IST
New Delhi [India], January 5 (ANI): The Subject Experts Committee (SEC) of the Drug Controller General of India (DCGI) on Wednesday granted approval to Bharat Biotech for conducting intranasal phase 3 trials and heterologous trials for COVID-19 booster intranasal vaccine for those who hav
Read More
SEC to hold meeting on Bharat Biotech's Nasal vaccine booster dose
Updated : 4 years, 4 months ago IST
New Delhi [India], January 4 (ANI): The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) is expected to meet on Tuesday afternoon to discuss Bharat Biotech's application for clinical trials of its intranasal Covid vaccine as a booster or a third dose.
Read More
Dr Dangs Lab as central lab conducted tests in all three trial phases of C
Updated : 4 years, 5 months ago IST
New Delhi [India], December 29 (ANI): With the Drug Controller General of India (DCGI) approving two new COVID-19 vaccines and one anti-viral drug for emergency use on Tuesday, Dr Arjun Dang, CEO, Dr Dangs Lab, welcomed the announcement and said they feel immensely proud "to have been a p
Read More
Biological E gets approval to conduct trials of Corbevax as booster dose
Updated : 4 years, 5 months ago IST
New Delhi [India], December 29 (ANI): The Drug Controller General of India (DCGI) has given approval to the Hyderbad-based pharmaceutical company Biological E to conduct phase 3 clinical trials of its COVID-19 vaccine Corbevax as a booster dose, said sources.
Read More
DCGI grants Cipla emergency use authorisation for COVID-19 drug Molnupirav
Updated : 4 years, 5 months ago IST
Mumbai (Maharashtra) [India], December 28 (ANI): Drug Controller General of India (DCGI) on Tuesday granted Emergency Use Authorisation (EUA) to Cipla for the launch of Molnupiravir in the country for COVID-19 treatment.
Read More
Zydus seeks DCGI nod for 'Desidustat' oral pill to treat anaemia in kidney
Updated : 4 years, 6 months ago IST
Ahmedabad (Gujarat) [India], November 23 (ANI): Pharmaceutical company Zydus Cadila on Tuesday announced that it has submitted its first "New Drug Application (NDA)" to the Drug Controller General of India for its oral pill "Desidustat" to treat anaemia in kidney patients.
Read More